Global Virus Network’s Position on the Administration of Booster Doses of the COVID-19 Vaccine
Scientists from the Global Virus Network (GVN) centers have discussed the World Health Organization’s request for a moratorium on the administration of a booster, or a third dose of the COVID-19 mRNA vaccine for Pfizer or Moderna recipients, while many around the world have not yet received their initial immunizations. Considering the emerging variants of…
SARS-CoV-2 Lambda Variant: The New Kid on the Block
SARS-CoV-2 Lambda Variant: The New Kid on the Block July 19, 2021 The COVID-19 pandemic has been marked by the ongoing emergence of new genetic variants. Although SARS-CoV-2 is an RNA virus, its genome is relative stable, thanks to a proofreading polymerase. However, in a situation with extensive viral transmission globally, the evolution of SARS-CoV-2…
Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy
Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy June 21, 2021 One of the consequences of unchecked SARS-CoV-2 infections is the generation of mutations that have the potential to increase infectivity and transmissibility, confer a degree of resistance to vaccines, neutralizing antibodies, and monoclonal antibody therapy, and in some cases generate false…
Vaccine Priorities: Children or Underserved Populations?
Vaccine Priorities: Children or Underserved Populations? May 24, 2021 In the setting of still somewhat limited vaccine supplies and deliveries, a current question is what the most effective priority is among those who are still not vaccinated. What will have the most effective dampening effect on the pandemic? There are several considerations. To what extent…
SARS-CoV-2 Transmission To, From, and Among Children: What’s New?
SARS-CoV-2 Transmission To, From, and Among Children: What’s New? April 30, 2021 The dynamics of infection of children has been of great interest, particularly as it pertains to the issue of whether or not to open schools and to vaccinate children. The discussions have at times been contentious. There are multiple aspects to the issue.…
Understanding Multisystem Inflammatory Syndrome in Children with COVID-19
Understanding Multisystem Inflammatory Syndrome in Children with COVID-19 April 16, 2021 Multisystem inflammatory syndrome in children (MIS-C) is a rare but is severe hyperinflammatory condition in children and adolescents. It is also known as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. This typically occurs 2–6 weeks after acute SARS-CoV-2 infection. Symptoms include persistent fever,…
COVID-19 Vaccine for Long-Haulers: A Surprising Benefit?
COVID-19 Vaccine for Long-Haulers: A Surprising Benefit? April 9, 2021 We are in the COVID-19 pandemic over one year now and still learning something new about SARS-CoV-2 and COVID-19. One of the serious and mysterious aspects of COVID-19 is long-term symptoms that persist for a significant period after SARS-CoV-2 infection as previously discussed. Many patients…
Correlates of Protection
Role of Correlates of Protection, or Immune Measurements, in Predicting Protective Immunity of COVID-19 Vaccines March 29, 2021 Broadly speaking, correlates of protection are measurements of immune parameters that allow prediction of the degree of protection against infection or disease induced by a pathogen. A prime point of interest in consideration of protection against SARS-CoV-2…
GLOBAL VIRUS NETWORK (GVN) ADDS SANOFI PASTEUR TO GVN HEALTHCARE & PHARMA CENTERS OF EXCELLENCE COALITION
The Partnership Focuses on Training The Next Generation of Virus Researchers to Safeguard Mankind from Current and Future Threats Baltimore, Maryland, USA, March 23, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, by training…